E-Cadherin is considered a tumor suppressor protein because it helps maintain cellular adhesion and tissue integrity. Loss or dysfunction of E-Cadherin can lead to increased cellular motility and a loss of cell polarity, which are hallmark features of cancer progression and metastasis. The downregulation or mutation of E-Cadherin is frequently observed in various types of cancers, including breast, gastric, and lung cancers.
